General Information of the Compound
Compound ID
CP0186668
Compound Name
6-[[(2S)-3-cyclopentyl-2-[4-(trifluoromethyl)imidazol-1-yl]propanoyl]amino]pyridine-3-carboxylic acid
    Show/Hide
Synonyms
PF-04991532
    Show/Hide
Structure
Formula
C18H19F3N4O3
Molecular Weight
396.369
Canonical SMILES
OC(=O)c1ccc(NC(=O)[C@H](CC2CCCC2)n2cnc(c2)C(F)(F)F)nc1
    Show/Hide
InChI
InChI=1S/C18H19F3N4O3/c19-18(20,21)14-9-25(10-23-14)13(7-11-3-1-2-4-11)16(26)24-15-6-5-12(8-22-15)17(27)28/h5-6,8-11,13H,1-4,7H2,(H,27,28)(H,22,24,26)/t13-/m0/s1
    Show/Hide
InChIKey
GKMLFBRLRVQVJO-ZDUSSCGKSA-N
CAS
1215197-37-7
Physicochemical Property
logP
3.7552
Rotatable Bonds
6
Heavy Atom Count
28
Polar Areas
97.11
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 46181428
SID: 96034675
ChEMBL ID
CHEMBL2165620
DrugBank ID
DB11765
Clinical Information about the Compound
Drug 1 ( PF-04991532 )
Drug Name PF-04991532
Company Pfizer
Indication
Diabetic complication
Phase 2
Target(s)
Glucokinase (GCK)
Activator